{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/creating-comprehensive-drug-development-plan#webpage",
"url": "https://www.fortrea.com/insights/creating-comprehensive-drug-development-plan",
"name": "Creating a comprehensive drug development plan",
"description": "This Fortrea white paper explores approaches for creating a comprehensive drug development plan across clinical development stages. The content focuses on drug development plan strategies, clinical development planning, study sequencing, regulatory alignment, development milestones, and cross-functional coordination affecting drug development programs. The white paper highlights factors related to development planning continuity, program sequencing, operational alignment, research prioritization, and strategic decision-making across clinical development activities. Fortrea discusses planning approaches designed to support structured development planning, strengthen coordination across research functions, and improve alignment between clinical, operational, and regulatory objectives. By integrating development planning with sequencing and coordination strategies, the white paper provides insights into creating a comprehensive drug development plan for clinical development success across evolving research programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Creating a comprehensive drug development plan",
"item": "https://www.fortrea.com/insights/creating-comprehensive-drug-development-plan"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/creating-comprehensive-drug-development-plan#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/creating-comprehensive-drug-development-plan#webpage"
},
"headline": "Building a Comprehensive Drug Development Plan Across Clinical Development Stages | Fortrea White Papern",
"description": "This Fortrea white paper explores approaches for creating a comprehensive drug development plan across clinical development stages. The content focuses on drug development plan strategies, clinical development planning, study sequencing, regulatory alignment, development milestones, and cross-functional coordination affecting drug development programs. The white paper highlights factors related to development planning continuity, program sequencing, operational alignment, research prioritization, and strategic decision-making across clinical development activities. Fortrea discusses planning approaches designed to support structured development planning, strengthen coordination across research functions, and improve alignment between clinical, operational, and regulatory objectives. By integrating development planning with sequencing and coordination strategies, the white paper provides insights into creating a comprehensive drug development plan for clinical development success across evolving research programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/creating-a-comprehensive-drug-development-plan.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/creating-a-comprehensive-drug-development-plan.pdf",
"encodingFormat": "application/pdf"
}
}
]
}